Respirology, 1323-7799


  1. 2020
  2. Ali, M., Kim, R., Brown, A., Vanka, K., Mayall, J., Liu, G., Pillar, A., Aryal, R., Jones, B., Xenaki, D., Borghuis, T., Karim, R., Pinkerton, J., Donovan, C., Heidari, M., Martin, K., Burgess, J., Oliver, B., Trinder, D., ... Horvat, J. (2020). CRITICAL ROLE FOR IRON ACCUMULATION IN THE PATHOGENESIS OF PULMONARY FIBROSIS. Respirology, 25, 92-92.
  3. Arellano-Maric, M. P., Hamm, C., Duiverman, M. L., Schwarz, S., Callegari, J., Storre, J. H., Schmoor, C., Spielmanns, M., Galetke, W., & Windisch, W. (2020). Obesity hypoventilation syndrome treated with non-invasive ventilation: Is a switch to CPAP therapy feasible? Respirology, 25(4), 435-442.
  4. 2019
  5. Park, H-S., Yoon, D., Lee, H. Y., Ban, G-Y., Wan Yau Ming, S., Jie, J. L. Z., Carter, V., Hardjojo, A., Van Boven, J. F. M., & Price, D. B. (2019). Real-life effectiveness of inhaler device switch from dry powder inhalers to pressurized metred-dose inhalers in patients with asthma treated with ICS/LABA. Respirology, 24(10), 972-979.
  6. Kostikas, K., Ryan, R., Fogel, R., Cao, H., Kocks, J., Agostoni, P., Rhee, C., Hurst, J., Jones, R., & Price, D. (2019). CHARACTERISTICS AND TREATMENT OF PATIENTS WITH COMORBID COPD AND HEART FAILURE. Respirology, 24, 125-125.
  7. 2018
  8. and the Groningen and Leiden Universities Corticosteroids in Obstructive Lung Disease (GLUCOLD) Study Group, Hartjes, F. J., Vonk, J. M., Faiz, A., Hiemstra, P. S., Lapperre, T. S., Kerstjens, H. A. M., Postma, D. S., & van den Berge, M. (2018). Predictive value of eosinophils and neutrophils on clinical effects of ICS in COPD. Respirology, 23(11), 1023-1031.
  9. Singapore International Respiratory Consortium (2018). International research collaboration: The way forward. Respirology, 23(7), 654-655.
  10. McKinstry, S., Pilcher, J., Bardsley, G., Berry, J., Van de Hei, S., Braithwaite, I., Fingleton, J., Weatherall, M., & Beasley, R. (2018). Nasal high flow therapy and PtCO2 in stable COPD: A randomized controlled cross-over trial. Respirology, 23(4), 378-384.
  11. 2017
  12. Rhee, C. K., Park, H. Y., Yoo, K. H., Kim, D. K., Park, H-S., Ming, S. W. Y., van Boven, J., Ling, J. Z. J., & Price, D. (2017). CHANGING ICS/LABA THERAPY FROM DPI TO PMDI: AN OBSERVATIONAL STUDY ON ASTHMA COST OUTCOMES IN SOUTH KOREA. Respirology, 22, 96.
  13. 2016
  14. Wan Yau Ming, S., Rhee, C. K., Park, H. Y., Yoo, K. H., Kim, D. K., Van Boven, J. F., Price, D., & Park, H. S. (2016). Real-life characteristics of asthma inhaler device use in South Korea. Respirology, 21, 170. [APSR6-0779].
  15. Zwerink, M., Kerstjens, H. A. M., van der Palen, J., van der Valk, P., Brusse-Keizer, M., Zielhuis, G., & Effing, T. (2016). (Cost-)effectiveness of self-treatment of exacerbations in patients with COPD: 2 years follow-up of a RCT. Respirology, 21(3), 497-503.
  16. Tang, F. S. M., Van Ly, D., Spann, K., Reading, P. C., Burgess, J. K., Hartl, D., Baines, K. J., & Oliver, B. G. (2016). Differential neutrophil activation in viral infections: Enhanced TLR-7/8-mediated CXCL8 release in asthma. Respirology, 21(1), 172-179.
  17. 2015
  18. Farah, C. S., Keulers, L. A. B., Hardaker, K. M., Peters, M. J., Berend, N., Postma, D. S., Salome, C. M., & King, G. G. (2015). Association between peripheral airway function and neutrophilic inflammation in asthma. Respirology, 20(6), 975-981.
  19. 2014
  20. Gompelmann, D., Eberhardt, R., Slebos, D-J., Brown, M. S., Abtin, F., Kim, H. J., Holmes-Higgin, D., Radhakrishnan, S., Herth, F. J. F., & Goldin, J. (2014). Diagnostic performance comparison of the Chartis System and high-resolution computerized tomography fissure analysis for planning endoscopic lung volume reduction. Respirology, 19(4), 524-530.
  21. 2013
  22. Ng, H. Y., Oliver, B. G. G., Burgess, J. K., Krymskaya, V. P., Black, J. L., & Moir, L. M. (2013). DOXYCYCLINE INHIBITS RHOA-GTPASE ACTIVITY IN MOUSE EMBRYONIC FIBROBLASTS. Respirology, 18, 49-49.
  23. Keller, M., Jaffar, J., Corte, T. J., Black, J. L., Webster, S., Troy, L., Corte, P., Torzillo, P., & Burgess, J. K. (2013). FIBULIN-1 AND PERIOSTIN LEVELS ARE ASSOCIATED WITH THE SEVERITY OF FIBROTIC LUNG DISEASE. Respirology, 18, 17-17.
  24. Fitzpatrick, M., Donovan, C., Esposito, J., Simoons, M., & Bourke, J. (2013). ROSIGLITAZONE, BUT NOT SALBUTAMOL, OPPOSES CONTRACTION TO DIVERSE AGONISTS IN SMALL AIRWAYS IN MOUSE LUNG SLICES. Respirology, 18, 40-40.
  25. Donovan, C., Esposito, J., Simoons, M., Royce, S., Tang, M. K., & Bourke, J. E. (2013). ROSIGLITAZONE IS A SUPERIOR DILATOR THAN B2-AGONISTS UNDER INFLAMMATORY CONDITIONS IN MOUSE SMALL AIRWAYS. Respirology, 18, 25-25.
  26. 2011
  27. Kuo, C., Lim, S., King, N. J. C., Bartlett, N. W., Walton, R. P., Zhu, J., Glanville, N., Aniscenko, J., Johnston, S. L., Burgess, J. K., Black, J. L., & Oliver, B. G. (2011). Rhinovirus infection induces expression of airway remodelling factors in vitro and in vivo. Respirology, 16(2), 367-77.
  28. 2010

ID: 5741246